Pleasanton, July 24, 2025 (GLOBE NEWSWIRE) -- Boster Bio pioneers free antibody validation, revolutionizing IHC services with guaranteed reagent reliability, setting new standards for reproducible ...
Boster Biological Technology (Boster Bio), a supplier of high-quality antibodies and immunoassays for over 30 years and a recipient of CiteAb recognition for antibody quality, announced a free ...
BOSTON--(BUSINESS WIRE)--Boston Cell Standards, a company standardizing cancer diagnostic tissue testing with the first immunohistochemistry (IHC) laboratory reference standards, today announced it ...
Prevalence of hypomagnesemia in patients with HER2–positive breast cancer receiving pertuzumab treatment. Analytical data demonstrating correlation of IHC results with HER2 receptor load and ...
Determining the BRAF mutation status of patients with advanced metastatic melanoma is essential in order to assess patients’ eligibility for targeted BRAF inhibitor therapy. The aim of this study was ...
(MENAFN- GetNews) With complementary validation services and the expansion of its IHC service lab, Boster Bio goes beyond being a product supplier, reinforcing its role as a partner in research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback